IL10 and Myocardial fibrosis: The mechanism by which immunotherapy with tDCs inhibits the progression of cardiac inflammation and myocardial fibrosis in a mouse model of CCC involves the secretion of IL-10 by tDCs to induce Tregs differentiation and enhance Tregs immunosuppressive function (164).